ArtNr |
PRS-96-597-0.1mg |
Hersteller |
ProSci
|
Menge |
0.1 mg |
Kategorie |
|
Typ |
Proteins Recombinant |
Format |
Lyophilized |
Applikationen |
WB |
Specific against |
other |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
PDCD1, PD1, CD279, SLEB2, hPD-1, hPD-l, PD-1 |
Lieferbar |
|
Applications |
This recombinant protein can be used for WB. For research use only. |
Applications |
This recombinant protein can be used for WB. For research use only. |
Buffer |
50 mM tris, 100 mM glycine, pH7.5 |
Storage Conditions |
Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles. |
Disclaimer |
Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures. |
Predicted Molecular Weight |
42.6 kDa |
Purity |
>95% as determined by SEC-HPLC and SDS-PAGE. |
Background |
Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-γ. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-γ secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer. |
1St Image Caption3 |
Human PD-1, Fc Tag, low endotoxin (HPLC-verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%. |
Background References 1 |
Ishida Y., et al., 1992, EMBO J. 11 (11): 3887–95. |
Background References 2 |
Blank C., et al., 2007, Cancer Immunol. Immunother. 56 (5): 739–45. |
Background References 3 |
Agata Y., et al., 1996, Int. Immunol. 8 (5): 765–72. |
Background References 4 |
Freeman GJ., et al., 2000, J. Exp. Med. 192 (7): 1027–34. |
Accession # |
NP_005009.2 |
Ncbi Gene Id # |
5133 |
Ncbi Official Symbol |
PDCD1 |
Ncbi Official Full Name |
programmed cell death 1 |
Ncbi Organism |
Homo sapiens |
Swissprot # |
Q15116 |
Fusion Tag |
C-Fc Tag |
Sequence |
Leu 25 - Gln 167 |
Biological Activity |
(1) Measured by its binding ability in a functional ELISA. Immobilized Human PD-L1, His Tag at 5 ug/mL (100 ul/well) can bind Human PD-1, Fc Tag (HPLC-verified) with a linear range of 0.05-1 ug/mL.(2) Measured by its binding ability in a functional ELISA. Immobilized Human PD-L2, His Tag at 5 ug/mL (100 ul/well) can bind Human PD-1, Fc Tag with a linear range of 0.02-0.5 ug/mL. |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.